Fruquintinib Plus FOLFIRI in RAS-mutated Metastatic Colorectal Cancer

NCT05842525 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: intensive treatment
DRUG: Maintenance treatment

Sponsor

Hunan Cancer Hospital

Collaborators

[object Object]